Hosted on MSN8mon
Teva wins FDA nod for new Austedo formulationA twice-daily formulation of Austedo was first authorized in the U.S. back in 2017. In early 2023, the Israeli drugmaker won FDA clearance for Austedo XR to market its extended-release version at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback